A heterologous prime-boost vaccination regimen using ORFF DNA and recombinant ORFF protein confers protective immunity against experimental visceral leishmaniasis.

Source:http://linkedlifedata.com/resource/pubmed/id/15898000

J. Infect. Dis. 2005 Jun 15 191 12 2130-7

Download in:

View as

Triples

General Info

PMID
15898000